Drug Shortage Report for APO-LANSOPRAZOLE

Last updated on 2019-08-19 History
Report ID 84125
Drug Identification Number 02293838
Brand name APO-LANSOPRAZOLE
Common or Proper name LANSOPRAZOLE
Company Name APOTEX INC
Active Ingredient(s) LANSOPRAZOLE
Strength(s) 30MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL
Packaging size 100 BTL
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-05-14
Estimated end date 2019-08-16
Actual end date 2019-08-16
Shortage status Resolved
Updated date 2019-08-19
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-08-19 French Compare
v5 2019-08-19 English Compare
v4 2019-06-07 French Compare
v3 2019-06-07 English Compare
v2 2019-05-15 French Compare
v1 2019-05-15 English Compare